My NCBI | Sign In
RSS Settings
  • Search: Sterling Timothy[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 60

    1.

    Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.

    Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, Moore RD.

    Clin Infect Dis. 2009 Nov 15;49(10):1582-90.PMID: 19845473 [PubMed - in process]Related articles

    2.

    Latent Tuberculosis Infection Treatment Acceptance and Completion in the United States and Canada.

    Horsburgh CR Jr, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, Hughes S, Shrestha-Kuwahara R, Sterling TR, Wall K, Weinfurter P; the Tuberculosis Epidemiologic Studies Consortium.

    Chest. 2009 Sep 30. [Epub ahead of print]PMID: 19793865 [PubMed - as supplied by publisher]Related articles

    3.

    Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.

    antiretroviral therapy cohort collaboration (ART-CC), Lanoy E, May M, Mocroft A, Phillip A, Justice A, Chêne G, Furrer H, Sterling T, Monforte AD, Force L, Gill J, Harris R, Hogg RS, Rockstroh J, Saag M, Khaykin P, de Wolf F, Sterne JA, Costagliola D.

    AIDS. 2009 Oct 23;23(16):2199-208.PMID: 19779320 [PubMed - in process]Related articles

    4.

    Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.

    Melekhin VV, Shepherd BE, Stinnette SE, Rebeiro PF, Barkanic G, Raffanti SP, Sterling TR.

    PLoS One. 2009 Sep 9;4(9):e6961.PMID: 19742315 [PubMed - in process]Related articlesFree article

    5.

    Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure.

    Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, May C, Smith T, Hooper N, Maruri F, Warkentin J, Mitchel E, Sterling TR.

    Am J Respir Crit Care Med. 2009 Aug 15;180(4):365-70. Epub 2009 May 29.PMID: 19483111 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of early versus deferred antiretroviral therapy for HIV on survival.

    Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD; NA-ACCORD Investigators.

    N Engl J Med. 2009 Apr 30;360(18):1815-26. Epub 2009 Apr 1.PMID: 19339714 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance.

    Devasia RA, Blackman A, May C, Eden S, Smith T, Hooper N, Maruri F, Stratton C, Shintani A, Sterling TR.

    J Antimicrob Chemother. 2009 Jun;63(6):1173-8. Epub 2009 Mar 28.PMID: 19329799 [PubMed - indexed for MEDLINE]Related articles

    8.

    Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.

    Lemly DC, Shepherd BE, Hulgan T, Rebeiro P, Stinnette S, Blackwell RB, Bebawy S, Kheshti A, Sterling TR, Raffanti SP.

    J Infect Dis. 2009 Apr 1;199(7):991-8.PMID: 19220139 [PubMed - indexed for MEDLINE]Related articles

    9.

    Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors.

    Asad S, Hulgan T, Raffanti SP, Daugherty J, Ray W, Sterling TR.

    J Natl Med Assoc. 2008 Dec;100(12):1417-24.PMID: 19110909 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators.

    Shepherd BE, Sterling TR, Moore RD, Raffanti SP, Hulgan T.

    J Clin Epidemiol. 2009 Jul;62(7):729-37. Epub 2008 Dec 23.PMID: 19108987 [PubMed - indexed for MEDLINE]Related articles

    11.

    Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy.

    Manabe YC, Breen R, Perti T, Girardi E, Sterling TR.

    J Infect Dis. 2009 Feb 1;199(3):437-44. Review.PMID: 19090776 [PubMed - indexed for MEDLINE]Related articles

    12.

    Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures.

    Rebeiro PF, Kheshti A, Bebawy SS, Stinnette SE, Erdem H, Tang YW, Sterling TR, Raffanti SP, D'Aquila RT.

    Clin Infect Dis. 2008 Nov 15;47(10):1354-7.PMID: 18922071 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    New approaches to the treatment of latent tuberculosis.

    Sterling TR.

    Semin Respir Crit Care Med. 2008 Oct;29(5):532-41. Epub 2008 Sep 22. Review.PMID: 18810686 [PubMed - indexed for MEDLINE]Related articles

    14.

    Misdiagnosis of HIV infection: implications for universal testing.

    Maddux DE, Reibero PF, Kheshti A, Sterling TR, Raffanti SP.

    AIDS. 2008 Feb 19;22(4):546-7. No abstract available. PMID: 18301073 [PubMed - indexed for MEDLINE]Related articles

    15.

    HIV in the workplace in Botswana: incidence, prevalence, and disease severity.

    Riviello ED, Sterling TR, Shepherd B, Fantan T, Makhema J.

    AIDS Res Hum Retroviruses. 2007 Dec;23(12):1453-60.PMID: 18160001 [PubMed - indexed for MEDLINE]Related articles

    16.

    Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease.

    Gaba PD, Haley C, Griffin MR, Mitchel E, Warkentin J, Holt E, Baggett P, Sterling TR.

    Arch Intern Med. 2007 Nov 26;167(21):2317-22.PMID: 18039990 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination.

    Sterling TR, Martire T, de Almeida AS, Ding L, Greenberg DE, Moreira LA, Elloumi H, Torres AP, Sant'Anna CC, Calazans E, Paraguassu G, Gebretsadik T, Shintani A, Miller K, Kritski A, Lapa e Silva JR, Holland SM.

    Pediatrics. 2007 Oct;120(4):e912-21.PMID: 17908747 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.

    Tai JH, Udoji MA, Barkanic G, Byrne DW, Rebeiro PF, Byram BR, Kheshti A, Carter JD, Graves CR, Raffanti SP, Sterling TR.

    J Infect Dis. 2007 Oct 1;196(7):1044-52. Epub 2007 Aug 29.PMID: 17763327 [PubMed - indexed for MEDLINE]Related articles

    19.

    Stability of antituberculosis drugs mixed in food.

    Peloquin CA, Durbin D, Childs J, Sterling TR, Weiner M.

    Clin Infect Dis. 2007 Aug 15;45(4):521. No abstract available. PMID: 17638210 [PubMed - indexed for MEDLINE]Related articles

    20.

    Extensively drug-resistant tuberculosis: are we learning from history or repeating it?

    Dukes Hamilton C, Sterling TR, Blumberg HM, Leonard M, McAuley J, Schlossberg D, Stout J, Huitt G.

    Clin Infect Dis. 2007 Aug 1;45(3):338-42. Epub 2007 Jun 22.PMID: 17599311 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    4 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity